Physician No program year No payments reported Source: CMS Open Payments, 2026 publication

Jorge Gonzalez

Nurse Practitioner, Family Miami, FL

NPI 1982648085 CMS profile 10518382

20841 S Dixie Hwy, Miami, FL 33189

Open in the dashboard

General payments

$0

None reported

Research payments

$0

Paid to them · None reported

Ownership & investment interest

$0

None reported

The CMS Open Payments record contains no reported payments to Jorge Gonzalez of Miami, FL.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

Prescribing to Medicare patients

Part D · data year 2024 · 199 drugs

Part D claims

16,855

Median for Nurse Practitioner: 389

Drug cost

$617,616

Median for Nurse Practitioner: $21,885

Branded share of claims

21.9%

Median for Nurse Practitioner: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Eliquis Apixaban Brand 399 $227,698
Xarelto Rivaroxaban Brand 96 $51,652
Entresto Sacubitril/Valsartan Brand 55 $36,984
Januvia Sitagliptin Phosphate Brand 23 $12,611
Brilinta Ticagrelor Brand 29 $12,505
Lantus Solostar Insulin Glargine,hum.Rec.Anlog Brand 188 $12,001
Abiraterone Acetate Generic 12 $10,786
Spiriva Handihaler Tiotropium Bromide Brand 22 $10,756
Insulin Aspart Flexpen Insulin Aspart Brand 65 $9,668
Budesonide-Formoterol Fumarate Budesonide/Formoterol Fumarate Brand 65 $9,263

The 10 drugs with the highest cost, of 199 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 229,976 Part D prescribers listed as Nurse Practitioner; they describe a distribution and say nothing about conduct.

Other Nurse Practitioner, Family in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record